HomePress-release

Redding, California - December 9, 2025

Transcriptomics Market to be Worth $15.32 Billion by 2035

Transcriptomics Market by Product & Services (Consumables, Instruments, Software & Services), Technology (Next-Generation Sequencing, PCR-based Technologies), Application (Drug Discovery & Development, Clinical Diagnostic), and End User - Global Forecast to 2035

Meticulous Research®—a leading market research company, published a research report titled, ' Transcriptomics Market by Product & Services (Consumables, Instruments, Software & Services), Technology (Next-Generation Sequencing, PCR-based Technologies), Application (Drug Discovery & Development, Clinical Diagnostic), and End User - Global Forecast to 2035”.

According to this latest publication from Meticulous Research®, the transcriptomics market is projected to reach $15.32 billion by 2035, at a CAGR of 6.3% from 2025 to 2035. The growth of the transcriptomics market is driven by the increasing demand for personalized medicine, rising prevalence of cancer and chronic diseases, advancements in next-generation sequencing technologies, growing applications in drug discovery and development, and increasing government funding and investments in genomics research. However, the market growth is restrained by the high cost of transcriptomic instruments and services, lack of skilled professionals for data analysis and interpretation, and stringent regulatory requirements for clinical applications.

Moreover, the emerging applications in spatial transcriptomics, integration of artificial intelligence and machine learning in data analysis, expanding applications in agricultural and environmental research, and growing adoption in emerging markets are expected to generate growth opportunities for market stakeholders. Data storage and management challenges and lack of standardization in transcriptomic workflows pose challenges to the growth of the market.

The key players profiled in the transcriptomics market report are Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Agilent Technologies, Inc. (U.S.), QIAGEN N.V. (Netherlands), Bio-Rad Laboratories, Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), 10x Genomics, Inc. (U.S.), Takara Bio Inc. (Japan), Oxford Nanopore Technologies Ltd. (U.K.), Pacific Biosciences of California, Inc. (U.S.), Merck KGaA (Germany), Bruker Corporation (U.S.), PerkinElmer, Inc. (U.S.), Fluidigm Corporation (U.S.), and Promega Corporation (U.S.).

The transcriptomics market is segmented by Product & Services, Technology, Application, and End User. The report also evaluates industry competitors and analyzes the transcriptomics market at the regional and country levels.

Among the product & services studied in this report, in 2025, the consumables segment is anticipated to dominate the transcriptomics market with a share of ~51%. The recurring and high-volume nature of consumable usage across RNA-based workflows, continuous consumption of reagents for every sample processed, rising adoption of NGS-based RNA-seq and single-cell transcriptomics, and advancements in library preparation chemistries and automation-compatible reagent kits are factors contributing to the segment's dominant position in the transcriptomics market.

Among the technologies studied in this report, in 2025, the next-generation sequencing segment is anticipated to dominate the transcriptomics market with a share of 70.7%. The comprehensive transcriptome coverage provided by NGS technologies, continuous decline in sequencing costs, superior ability to detect novel transcripts and splice variants, and growing adoption of single-cell and spatial transcriptomics applications are factors contributing to the segment's dominant position in the transcriptomics market.

Among the applications studied in this report, in 2025, the drug discovery & development segment is anticipated to dominate the transcriptomics market with a share of ~35%. The extensive use of transcriptomics throughout pharmaceutical development pipelines, growing investments in biologics and precision medicine, increasing adoption of target-based drug discovery approaches, and expanding applications in biomarker discovery for patient stratification are factors contributing to the segment's dominant position in the transcriptomics market.

Among the end users studied in this report, in 2025, the pharmaceutical & biotechnology companies segment is anticipated to dominate the transcriptomics market. The extensive use of transcriptomics in drug discovery and development pipelines, growing investments in precision medicine initiatives, increasing adoption of transcriptomics in clinical trials for patient stratification, and ongoing development of RNA-based therapeutics are factors contributing to the segment's dominant position in the transcriptomics market.

Among geographies, in 2025, North America is anticipated to dominate the transcriptomics market. The large share of this regional market is attributed to factors such as the strong presence of leading biotechnology and pharmaceutical companies, well-established genomics research infrastructure, high adoption of advanced sequencing technologies, substantial government and private funding for genomics research, and early adoption of transcriptomic diagnostics in clinical practice in the region.

However, Asia-Pacific is projected to register the highest CAGR of 7.6% during the forecast period. Increasing investments in genomics research infrastructure, growing pharmaceutical and biotechnology sectors in countries like China and India, rising healthcare expenditure and improving access to advanced diagnostics, expanding academic research collaborations with Western institutions, and government initiatives supporting precision medicine and genomics programs are the key factors driving the market growth in Asia-Pacific.

Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=6319

Key questions answered in the report-

Which are the high-growth market segments in terms of transcriptomics by product & services, technology, application, end user, and geography?
What was the historical market for transcriptomics across the globe?
What are the market forecasts and estimates for the period 2025–2035?
What are the major drivers, restraints, opportunities, and challenges in the transcriptomics market?
Who are the major players operating in the transcriptomics market?
What is the competitive landscape like, and who are the leaders in the transcriptomics market?
What are the recent developments in the transcriptomics market?
What are the different strategies adopted by the major players in the transcriptomics market?
What are the geographical trends and high-growth regions/countries?

Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research

3D Printing

5G Technology

Advanced Chemical & Materials

Agrochemicals

Algae Products

Alternative Proteins

Animal Health

Artificial Intelligence

Automotive Technologies

Big Data Analytics

Climate Technologies

Edible Insects

Electric Vehicle

Food & Agriculture Technologies

Hydrogen Technologies

Internet Of Things

In Vitro Diagnostics

Laboratory Instrumentation

Language Learning Technologies

Medical Technologies

Next Generation Technologies

Processing & Packaging Technologies

Robotics & Automation

Smart Technologies

Water & WastewaterTechnologies

Miscellaneous / Others

Redding, California - December 9, 2025

Transcriptomics Market to be Worth $15.32 Billion by 2035

Transcriptomics Market by Product & Services (Consumables, Instruments, Software & Services), Technology (Next-Generation Sequencing, PCR-based Technologies), Application (Drug Discovery & Development, Clinical Diagnostic), and End User - Global Forecast to 2035

Recommended Readings

Advanced Chemical &
Materials

Food & Agriculture
Technologies

Next Generation
Technologies

Processing & Packaging
Technologies

Water & Wastewater
Technologies